Eli Lilly & Co. (LLY)
| Sector: | Health Care |
| Super Investor Stats: | |
| Ownership count: | 6 |
| Ownership rank: | 66 |
| % of all portfolios: | 0.092% |
| Hold Price * : | $885.95 |
| Total insider Buys/Sells last 6 months: |
| Transactions | Total |
| Buys |
0 |
$0 |
| Sells |
163 |
$1,746,243,876 |
|
Portfolio Manager |
% of portfolio |
Recent activity |
Shares |
Value |
| ≡ |
Chase Coleman - Tiger Global Management |
3.67 |
Add 4.28% |
969,800 |
859,185,000 |
| ≡ |
Mairs & Power Growth Fund |
1.94 |
|
124,539 |
110,334,000 |
| ≡ |
Polen Capital Management |
1.12 |
Reduce 10.44% |
489,955 |
434,070,000 |
| ≡ |
Viking Global Investors |
0.49 |
Add 5.45% |
152,038 |
134,697,000 |
| ≡ |
Torray Funds |
0.05 |
Buy |
398 |
353,000 |
| ≡ |
David Katz - Matrix Asset Advisors |
0.03 |
Add 1.68% |
302 |
268,000 |
* "Hold Price" is the last known price at which an investor still held a security. It is the closing price of the security as of the portfolio date (quarter end). This value is only provided when a security is owned by at least two investors. In the case of reporting dates being different, a weighted average price is calculated.
P = Preferred Stock